Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06456554 · ClinicalTrials.gov registry record · NA
Acellular Dermal Matrix Investigation in Breast Reconstruction
A NA study of Breast Reconstruction, sponsored by RTI Surgical.
- Recruiting
- Registry status
- NA
- Development phase
- 467
- Enrollment target
- 10
- Study locations
NCT06456554: Recruiting NA study of Breast Reconstruction, sponsored by RTI Surgical.
NCT06456554 is a NA study of Breast Reconstruction that is actively recruiting participants, run by RTI Surgical. The registered enrollment target is 467 participants, above the 368-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (27% higher). The trial reports 10 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06456554, a NA study of Breast Reconstruction, is actively recruiting participants, sponsored by RTI Surgical.
- RECRUITING
- Registry status
- NA
- Development phase
- 467 participants
- Enrollment target
- 10
- Study locations
Study Summary
Prospective, multi-center, dual-arm non-randomized clinical study in females undergoing a two-stage breast reconstruction using a pre-pectoral technique.
Primary Outcome
Surgery-related adverse events requiring rehospitalization or reoperation of the breast under study
Conditions Studied
Interventions
- DEVICE Acellular Dermal Matrix (Cortiva Tissue Matrix)
Study Locations (10)
Missouri
- Washington University - St Louis
- Mercy Hospital - St Louis
New York
- NYU Langone Health - New York
- New York Presbyterian Hospital/Columbia University Irving Medical Center - New York
Arkansas
- University of Arkansas - Little Rock
California
- City of Hope National Medical Center - Duarte
Colorado
- University of Colorado - Aurora
Ohio
- Cleveland Clinic - Cleveland
Oklahoma
- Mercy Hospital - Oklahoma City
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 467 participants |
| Start Date | 2024-11-22 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT06456554 shows while recruiting
NCT06456554 is an interventional study that assigns participants to a tested intervention. The registered 467 participants enrollment target is mid-sized for trials with a published cap, above the 368-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (27% higher).
The record links to 1 condition, with Breast Reconstruction appearing as the primary indexed condition, and to 1 intervention - of which Acellular Dermal Matrix (Cortiva Tissue Matrix) is the first listed.
NCT06456554 lists 10 locations in 8 states (Missouri, New York, Arkansas).
Frequently Asked Questions
What is clinical trial NCT06456554 about?
NCT06456554 is a clinical study titled "Acellular Dermal Matrix Investigation in Breast Reconstruction". Prospective, multi-center, dual-arm non-randomized clinical study in females undergoing a two-stage breast reconstruction using a pre-pectoral technique.
What is the current status of trial NCT06456554?
This trial is currently recruiting. It is a NA study. The enrollment target is 467 participants. The study started on 2024-11-22. Estimated completion is 2027-12.
What conditions does trial NCT06456554 study?
This clinical trial studies the following conditions: Breast Reconstruction.
What interventions are being tested in trial NCT06456554?
The interventions under investigation include: Acellular Dermal Matrix (Cortiva Tissue Matrix) (DEVICE).
Who is sponsoring clinical trial NCT06456554?
This trial is sponsored by RTI Surgical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06456554 being conducted?
This trial has 10 study locations across Arkansas, California, Colorado, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Reconstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06456554's enrollment target sits among peer trials
467 6th of 18 higher than 13 of 18 other Breast Reconstruction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Reconstruction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study on Pain After Breast Reconstruction
RECRUITING · NA
-
Melodi Matrix™ in Breast Reconstruction
RECRUITING · NA
-
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
RECRUITING · NA
-
Impact of Pectoral Versus Paravertebral Blocks on Pain and Physical Well-Being in Implant-Based Breast Reconstruction
RECRUITING · NA
-
Pulsed Lavage in Implant-Based Breast Reconstruction
RECRUITING · NA
-
SAVE Trial: SAfe Opioid Use Video Education
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03124303 · 468 participants
Interventions for Postoperative Delirium: Biomarker-3
- NCT03901924 · 468 participants · NA
Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy
- NCT04482309 · 468 participants · Phase 2
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
- NCT05357170 · 468 participants
Microbiome Dysfunction in Surgical Intensive Care Unit Survivors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI